| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Keenova Therapeutics plc | Director | Ordinary Shares | 8,031 | $712,751 | $88.75 | 01 Jan 2026 | By JZ Advisors LLC |
| Keenova Therapeutics plc | Director | Restricted Stock Units | 35,570 | 01 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465926000785-zinman-jon-2026-01-01 | Keenova Therapeutics plc | 01 Jan 2026 | 2 | $0 | 4 | Director | 05 Jan 2026, 18:05 |
| /report/000110465925079950-zinman-jon-2025-08-14 | Mallinckrodt plc | 14 Aug 2025 | 1 | $0 | 4 | Director | 18 Aug 2025, 21:07 |
| /report/000110465925073797-zinman-jon-2025-07-31 | Mallinckrodt plc | 31 Jul 2025 | 1 | $0 | 4 | Director | 04 Aug 2025, 20:53 |
| /report/000110465925000378-zinman-jon-2025-01-01 | Mallinckrodt plc | 01 Jan 2025 | 2 | $0 | 4 | Director | 02 Jan 2025, 17:05 |
| /report/000110465924025536-zinman-jon-2024-02-19 | Mallinckrodt plc | 19 Feb 2024 | 1 | $0 | 4 | Director | 20 Feb 2024, 16:20 |
| /report/000110465923120832-zinman-jon-2023-11-14 | Mallinckrodt plc | 14 Nov 2023 | 0 | $0 | 3 | Director | 22 Nov 2023, 18:53 |